Cancer immunology and immunotherapy [PDF]
Cancer Biology & Medicine, 2021 Xiubao Ren1,2,3 1Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China; 2Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital,
Xiubao Ren
doaj +8 more sources
Cancer Immunology and Cancer Immunodiagnosis [PDF]
Journal of Immunology Research, 2014 Cancer immunology is the study of interactions between the immune system and cancer cells, which is a rapid growing field of research that aims to identify biomarkers in cancer immunodiagnosis and to develop innovative cancer immunotherapeutic strategies.
Jianying Zhang +3 more
doaj +10 more sources
Biomarkers and experimental models for cancer immunology investigation [PDF]
MedComm, 2023 The rapid advancement of tumor immunotherapies poses challenges for the tools used in cancer immunology research, highlighting the need for highly effective biomarkers and reproducible experimental models.
Hengyi Xu +12 more
doaj +3 more sources
Novel Mouse Models for Cancer Immunology. [PDF]
Annu Rev Cancer Biol, 2022 Mouse models for the study of cancer immunology provide excellent systems in which to test biological mechanisms of the immune response against cancer. Historically, these models have been designed to have different strengths based on the current major ...
Connolly KA +3 more
europepmc +2 more sources
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program [PDF]
Journal of Translational Medicine, 2011 The Society for Immunotherapy of Cancer, SITC (formerly the International Society for Biological Therapy of Cancer, iSBTc), aims to improve cancer patient outcomes by advancing the science, development and application of biological therapy and ...
Urba Walter J +3 more
doaj +5 more sources
Dendritic Cells in Cancer Immunology and Immunotherapy. [PDF]
Cancers (Basel)Simple Summary Although immune check point inhibitors have been established as a new paradigm in cancer treatment, they have shown no clinical benefit in immune excluded or dessert tumors.
Hato L +9 more
europepmc +2 more sources
TNFR2: Role in Cancer Immunology and Immunotherapy. [PDF]
Immunotargets Ther, 2021 Immune checkpoint inhibitors (ICIs), including anti-CTLA-4 (cytotoxic T lymphocyte antigen-4) and anti-PD-1/PD-L1 (programmed death-1/programmed death-ligand 1), represent a turning point in the cancer immunotherapy.
Yang Y, Islam MS, Hu Y, Chen X.
europepmc +2 more sources
Histamine in cancer immunology and immunotherapy. Current status and new perspectives. [PDF]
Pharmacol Res Perspect, 2021 Cancer is the second leading cause of death globally and its incidence and mortality are rapidly increasing worldwide. The dynamic interaction of immune cells and tumor cells determines the clinical outcome of cancer. Immunotherapy comes to the forefront
Sarasola MP +3 more
europepmc +2 more sources
JTM’s Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section [PDF]
Journal of Translational Medicine, 2013 For the last four years the Journal of Translational Medicine (JTM) has hosted the Section of Tumor Immunology and Biological Cancer Therapy. Under the editorial leadership of Dr.
Bot Adrian +2 more
doaj +5 more sources
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium. [PDF]
Cancer Immunol Res, 2023 The Arthur and Sandra Irving Cancer Immunology Symposium has been created as a platform for established cancer immunologists to mentor trainees and young investigators as they launch their research career in the field. By sharing their different paths to
Alvarez-Breckenridge C +25 more
europepmc +3 more sources